Effect of TU-100 in Patients With Functional Constipation

Summary

The primary objective of this study is to evaluate the improvement in the severity of constipation (from Baseline to Day 28), determined by the constipation severity instrument (CSI) score \[1\], compared to placebo, following a total daily oral dose of 15 g TU-100 administered for 28 consecutive days in adult subjects with functional constipation.

Timeline

Start

2011-09

Primary completion

2013-07

Completion

2013-07

Drugs

Indications